Antithrombotic therapy in cardiac stent patients

Related Experiment Video

Updated: Oct 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

C R Cannan1

  • 1Division of Cardiovascular Diseases, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA. cannanc@ohsu.edu

Current Cardiology Reports
|January 5, 2001
PubMed

Insights

Coronary stents improve angioplasty outcomes, but antiplatelet therapy is crucial. Antiplatelet agents significantly reduce complications and improve long-term results after stent placement.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Coronary stents have revolutionized percutaneous coronary intervention, improving immediate outcomes.
  • Restenosis and repeat procedures remain significant challenges after coronary angioplasty.
  • Adjuvant antithrombotic therapy, particularly targeting platelet function, is essential for successful stent deployment.

Purpose of the Study:

  • To review the historical evolution of antithrombotic therapy used with coronary stents.
  • To discuss currently utilized antiplatelet agents in stent procedures.
  • To explore future therapeutic strategies in antithrombotic therapy for coronary stenting.

Main Methods:

  • Literature review of studies on antithrombotic therapy and coronary stents.
  • Analysis of clinical trial data on antiplatelet agents.
  • Synthesis of current guidelines and emerging research.

Main Results:

  • Coronary stents significantly enhance immediate angiographic success.
  • Antiplatelet therapy has dramatically reduced restenosis rates and the need for reintervention.
  • Improved long-term outcomes are directly attributable to effective antithrombotic regimens.

Conclusions:

  • Adjuvant antiplatelet therapy is indispensable for optimizing outcomes after coronary stent placement.
  • The evolution of these agents has been critical in minimizing complications.
  • Ongoing research aims to further refine antithrombotic strategies for even better patient results.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...